Characterization of Extramedullary Disease (EMD) Response to CD19 Targeted Chimeric Antigen Receptor T-Cells (CART) in Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL): A Multi-Site, Retrospective Cohort Review
Alexander W. Rankin(National Institutes of Health), Susan R. Rheingold(Children's Hospital of Philadelphia), Nirali N. Shah(National Institutes of Health), Deepa Bhojwani(St. Jude Children's Research Hospital), Emily M. Hsieh(Children's Hospital of Los Angeles), Bonnie Yates(National Institutes of Health), Lia Gore(Children's Hospital Colorado), Adam J. Lamble(Seattle Children's Hospital), Seth M. Steinberg(National Institutes of Health), Sara Silbert(National Institutes of Health), Amanda M. DiNofia(Children's Hospital of Philadelphia), Jennifer Sheppard(Southwestern Medical Center), Daniel W. Lee(University of Virginia Cancer Center), Stephan A. Grupp(Children's Hospital of Philadelphia), Rebecca Gardner(Seattle Children's Hospital), Mike A. Pulsipher(Primary Children's Hospital), Regina M. Myers(Children's Hospital of Philadelphia), Lee Chen(Children's Hospital of Philadelphia), Colleen Annesley(Unknown), Samuel John(Southwestern Medical Center)
Cited by 4
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817